Medicare’s negotiated 2027 prices on 15 top drugs, including Ozempic, take effect January 1 and could lower what seniors pay.
Starting January 1, 2027, Medicare’s second round of drug price negotiation kicks in, applying government-set ceilings to 15 of the most heavily used medications in the Part D program. The list runs from blood thinners and cancer treatments to the diabetes drug semaglutide, sold as Ozempic. Whether an individual retiree sees a smaller bill depends…